Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 810 results for "daiichi sankyo company"

Sun Pharma terminates transaction agreements with Daiichi Sankyo
United News of India

Sun Pharma rises on terminating transaction agreements with Da...

SENSEX 26642.70 276.02 1.05% NIFTY 8147.15 77.50 0.96% Industry: Medical/Healthcare Company Sun Pharmaceutical Industries Ltd Sun Pharmaceutical Industries is currently trading at Rs. 818.75, up by 38.70 points or 4.96% from ... Finalaya.com, 1 day ago

6 images for daiichi sankyo company

Reuters, 2 weeks ago
Reuters India, 3 weeks ago
Yahoo! India, 2 weeks ago
Yahoo! India, 3 weeks ago
Stock Nod, 1 month ago
StatNews.com, 2 weeks ago
Finchannel.com

Japanese pharma companies unite to establish biomarker database on healthy adults

Japanese pharma companies Astellas Pharma, Daiichi Sankyo Company and Takeda Pharmaceutical have entered into a joint research agreement to comprehensively acquire and analyse fundamental biomarker data on healthy adult volunteers in order to ...
 Pharma Business International2 days ago Astellas, Daiichi Sankyo and Takeda to analyse biomarker data on healthy adults  CPhI.cn2 days ago Astellas, Daiichi Sankyo, Takeda to co-create large Biomarker Database  Bio Spectrum Asia5 days ago Astellas, Daiichi Sankyo & Takeda enter research collaboration on establishing biomarker database on healthy adults  PharmaBiz4 days ago
[x]  
Rediff.com

DAIICHI SANKYO : Launches Antiplatelet Agent Efient® Tablets 20mg

Company name: DAIICHI SANKYO COMPANY, LIMITED Representative: Joji Nakayama, Representative Director, President and CEO (Code no.: 4568, First Section, Tokyo Stock Exchange) Please address inquiries to Noriaki Ishida, Executive Officer, Vice ...
 4 Traders3 days ago Daiichi Sankyo introduces antiplatelet agent Efient tablets 20mg in Japan  PharmaBiz1 day ago Daiichi Sankyo launches antiplatelet agent Efient in Japan...  Bio Spectrum Asia3 days ago Daiichi Sankyo to develop Cell Therapy's Heartcel for Japanese...  Bio Spectrum Asia1 week ago
[x]  

Nitto, Daiichi Sankyo partner to commercialise active transdermal drug delivery technology, PassPort System

Nitto Denko Corporation announced the signing of a partnership agreement with global pharmaceutical company Daiichi Sankyo Company, Ltd that will utilize Nitto's proprietary PassPort active transdermal drug delivery technology. Based on this ...
 PharmaBiz2 weeks ago Nitto Denko inks mystery deal with Daiichi for U.S. use of transdermal patch  FierceMedicalDevices2 weeks ago Nitto Denko enters drug delivery partnership with Daiichi Sankyo  Manufacturing Chemist2 weeks ago Nitto Signs Partnership Agreement with Daiichi Sankyo: Accelerates the Commercialization of Nitto's Active Transdermal Drug Delivery Technology PassPort® System  4 Traders2 weeks ago
[x]  
Yahoo! India

Daiichi takes legal steps to secure Ranbaxy arbitration award

Tokyo-based Daiichi Sankyo has asked an Indian court to make sure former Ranbaxy owners Malvinder and Shivinder Singh set aside enough capital to meet an arbitration award that could reach $525 million. Earlier this month, the brothers were ...
 FiercePharma2 days ago Daiichi snaps up Japanese rights to CVD stem-cell therapy  BioPharma Dive2 weeks ago Daiichi buys Japanese rights to UK heart stem cell therapy  4 Traders2 weeks ago Daiichi Sankyo awarded damages from former Ranbaxy owners  RSC2 weeks ago
[x]  
Equitymaster.com

Global Opioid Induced Constipation (OIC) Drugs Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2012 To 2022

1 of 4 FEATURED COMPANIES Astrazenenca Daiichi Sankyo Co. Ltd. Pfizer Salix Pharmaceuticals Ltd Shionogo & Co Ltd Sucampo Pharmaceuticals MORE This new market research report forecasts on Opioid Induced Constipation (OIC) Drugs Market ...
 Research and Markets4 days ago Global Relapsed Acute Myeloid Leukemia Pipeline Report 2016 - Review of 52 Companies & Drug Profiles - Research and Markets  4 Traders2 days ago Global Measles Report 2016 - Pipeline Review of 10 Companies & Drug Profiles - Research and Markets  4 Traders2 days ago Measles Drugs and Companies Report Analysis 2016  Before It's News1 day ago
[x]  

Daiichi Sankyo licenses off-the-shelf regenerative heart cell therapy from CTL

Daiichi Sankyo has paid Cell Therapy Ltd £12.5m ($18m) for the Japanese rights to its cardiac regeneration candidate Heartcel, made from allogeneic stem cells. Heartcel is an immune-modulatory progenitor (iMP) cell therapeutic agent, made from ...
 BioPharma-Reporter.com2 weeks ago Cell Therapy Ltd. Grants Japan License To Daiichi Sankyo For Its Heart Regeneration Medicine, Heartcel  Minyanville2 weeks ago Cell Therapy grants Japanese licence for Heartcel to Daiichi Sankyo  CPhI.cn2 weeks ago Cell Therapy Grants Japan License To Daiichi Sankyo For Its Heart Regeneration Medicine, Heartcel  BioSpace2 weeks ago
[x]  

DAIICHI SANKYO : Differences Between Consolidated Results for Fiscal 2015 and Fiscal 2014

Company name: DAIICHI SANKYO COMPANY, LIMITED Representative: Joji Nakayama, Representative Director, President and CEO (Code no.: 4568, First Section, Tokyo Stock Exchange) Please address inquiries to Noriaki Ishida, Executive Officer, Vice ...
 4 Traders2 weeks ago DAIICHI SANKYO : Announces Changes to Representative Director and Members of the Board  4 Traders2 weeks ago Daiichi Sankyo Announces Changes to Representative Director and Members of the Board  FirstWord Pharma2 weeks ago
Rediff.com

Singh brothers may contest court ruling

Singapore arbitration award favours Daiichi Sankyo Malvinder Mohan Singh and Shivinder Mohan Singh, the former promoters of Ranbaxy Laboratories are mulling a challenge to a Singapore arbitration court ruling asking them to pay damages of Rs ...
 The Hindu3 weeks ago Don't need to sell assets, can pay fine: Ranbaxy brothers  Rediff.com3 days ago Former Promoters Of Pharma Company Ranbaxy Fined Rs 2500 Crore By A Singapore Court  Indiatimes3 weeks ago Ranbaxy brothers asked to pay Daiichi Rs 2,500 crore  Asian Age3 weeks ago
[x]  
Moneycontrol.com

Daiichi Sankyo moves further to cut legacy Ranbaxy ties

Tokyo-based Daiichi Sankyo has further cut legacy ties to Ranbaxy Laboratories in a mutual agreement with Sun Pharmaceutical Industries to terminate transaction agreements connected to the firm. Mumbai-based Sun bought Ranbaxy in an all-stock ...
 FiercePharma1 day ago Sun Pharma, Daiichi terminate transaction pacts  Moneycontrol.com2 days ago
[x]  
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - daiichi sankyo company
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less